Creso Pharma Ltd. (ASX:CPH) released the company's June investor presentation on Wednesday along with an update on upcoming product launches and we think it’s worth a look. Scroll through the slides above for an in-depth look at what's going on at Creso Pharma.
Update on Product Launches
In addition to the presentation, Creso released an update regarding the company's upcoming product launches. The company is on track to launch their CannaQix nutraceutical product for anxiety and stress in humans in the first half of 2018 as well as a line extension for bone metabolism in the second quarter of 2019. Creso is also on track to launch their hemp-based companion and zoo animal feed products in 2017.
In Wednesday's trading on the ASX, shares of Creso Pharma Ltd. gained more than 3%. Year-to-date, shares of Creso Pharma are up more than 138%!
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.